MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ajoc.2022.101309

Медицинская библиотека · American journal of ophthalmology case reports · 2022

Topical treatment of dupilumab-associated refractory conjunctivitis and keratitis.

Di Staso Federico, Lambiase Alessandro, Silvio Di Staso, Gattazzo Irene, Ciancaglini Marco, Scuderi Gianluca

Клинический случайСтатьяПеревод в очереди

Аннотация

PURPOSE: To report 3 cases of severe dupilumab-related conjunctivitis and keratitis topical treatment.

OBSERVATION: Description, management, and outcomes of dupilumab-related refractory conjunctivitis associated with punctate keratitis.Three patients with atopic dermatitis (AD) experiencing severe ophthalmic complications following dupilumab treatment were referred to us when conventional management methods failed. We treated them topical and external pimecrolimus 10 mg/g cream to the eyelids. The patients showed substantial clinical remission within 10 days.

CONCLUSIONS AND

IMPORTANCE

Those cases are remarkable as a drug applied externally to the eyelid skin successfully treated underlying conjunctivitis and punctate keratitis. The complete clinical remission suggests that pimecrolimus applied topically to the eyelid skin is a safe and effective delivery route. The resolution of the keratitis and conjunctivitis presumably represents either a contiguous effect of the improvement of the cutaneous inflammation, or the effect of transcutaneous pimecrolimus penetration through the eyelid.Further studies are needed to support the use of this drug for dupilumab-associated conjunctivitis.

Для цитирования: Di Staso Federico, Lambiase Alessandro, Silvio Di Staso, Gattazzo Irene, Ciancaglini Marco, Scuderi Gianluca. Topical treatment of dupilumab-associated refractory conjunctivitis and keratitis.. American journal of ophthalmology case reports. 2022. DOI: 10.1016/j.ajoc.2022.101309.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.